Consistently, MITF silencing showed similar cell growth inhibition in high-MITF–expressing melanoma cells but no effect in low-MITF–expressing cells (Fig 4B), indicating that DUSP4 function is critical for both NRAS- and BRAF-mutant melanoma cells that rely on the MITF pathway. This evidence concerns the gene BRAF and melanoma.